Francyelli Mello-Andrade

5PUBLICATIONS
20CO-AUTHORS
Metal organic frameworksCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 26, 2023
"Half-Sandwich" Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies.

João Honorato de Araujo-Neto, Adriana P M Guedes, Celisnolia M Leite

|Apr 10, 2021
Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets.

Ingrid O Travassos, Francyelli Mello-Andrade, Raíssa P Caldeira

|Apr 09, 2020
Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity.

Raquel Santos Faria, Hugo Delleon Silva, Francyelli Mello-Andrade

|Nov 28, 2019
Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action.

Aliny Pereira de Lima, Marcio Aurélio Pinheiro Almeida, Francyelli Mello-Andrade

Pageof 1